These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 28679859)

  • 1. Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry.
    Mazurek M; Shantsila E; Lane DA; Wolff A; Proietti M; Lip GYH
    Stroke; 2017 Aug; 48(8):2198-2205. PubMed ID: 28679859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary stroke prevention and guideline adherent antithrombotic treatment in patients with atrial fibrillation: Insights from the Gulf Survey of atrial fibrillation events (Gulf SAFE).
    Miyazawa K; Li YG; Rashed WA; Al Mahmeed W; Shehab A; Zubaid M; Lip GYH
    Int J Cardiol; 2019 Jan; 274():126-131. PubMed ID: 30064925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline-Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation: Insights From the Community-Based Darlington Atrial Fibrillation Registry.
    Mazurek M; Shantsila E; Lane DA; Wolff A; Proietti M; Lip GYH
    Mayo Clin Proc; 2017 Aug; 92(8):1203-1213. PubMed ID: 28778255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project.
    Gorin L; Fauchier L; Nonin E; Charbonnier B; Babuty D; Lip GYH
    Chest; 2011 Oct; 140(4):911-917. PubMed ID: 21436246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries.
    Miyazawa K; Ogawa H; Mazurek M; Shantsila E; Lane DA; Wolff A; Akao M; Lip GYH
    Circ J; 2019 Nov; 83(12):2434-2442. PubMed ID: 31694989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study.
    Proietti M; Nobili A; Raparelli V; Napoleone L; Mannucci PM; Lip GY;
    Clin Res Cardiol; 2016 Nov; 105(11):912-920. PubMed ID: 27245329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of In-Hospital Recommendation and Prescription of Anticoagulants for Secondary Prevention of Stroke after Launch of Direct Oral Anticoagulants and Change of National Guidelines.
    Gronemann C; Hause S; Assmann A; Neumann J; Schreiber S; Heinze HJ; Goertler M
    Cerebrovasc Dis; 2020; 49(4):412-418. PubMed ID: 32756054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice.
    Wolff A; Shantsila E; Lip GY; Lane DA
    Age Ageing; 2015 Sep; 44(5):874-8. PubMed ID: 26082176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry.
    Li YG; Miyazawa K; Wolff A; Zubaid M; Alsheikh-Ali AA; Sulaiman K; Lip GYH
    Int J Cardiol; 2019 Jan; 274():158-162. PubMed ID: 30291008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.
    Shantsila E; Wolff A; Lip GY; Lane DA
    Br J Gen Pract; 2015 Jan; 65(630):e16-23. PubMed ID: 25548312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population: The COOL-AF Registry.
    Krittayaphong R; Winijkul A; Kunjara-Na-Ayudhya R; Apiyasawat S; Siriwattana K; Kanjanarutjawiwat W; Dutsadeevettakul S; Lip GYH;
    Stroke; 2020 Jun; 51(6):1772-1780. PubMed ID: 32390554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary management of atrial fibrillation in primary and secondary care in the UK: the prospective long-term AF-GEN-UK Registry.
    Shantsila A; Lip GYH; Lane DA
    Europace; 2023 Feb; 25(2):308-317. PubMed ID: 36037021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation: The Fushimi Atrial Fibrillation Registry.
    Takabayashi K; Hamatani Y; Yamashita Y; Takagi D; Unoki T; Ishii M; Iguchi M; Masunaga N; Ogawa H; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GY; Akao M
    Stroke; 2015 Dec; 46(12):3354-61. PubMed ID: 26514188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.
    Camm AJ; Accetta G; Ambrosio G; Atar D; Bassand JP; Berge E; Cools F; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Kayani G; Koretsune Y; Mantovani LG; Misselwitz F; Oh S; Turpie AG; Verheugt FW; Kakkar AK;
    Heart; 2017 Feb; 103(4):307-314. PubMed ID: 27647168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving stroke prevention in patients with atrial fibrillation.
    Arts DL; Abu-Hanna A; Büller HR; Peters RJ; Eslami S; van Weert HC
    Trials; 2013 Jul; 14():193. PubMed ID: 23815891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.